Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

4.36
+0.410010.38%
Post-market: 4.390.0300+0.69%19:59 EDT
Volume:35.50M
Turnover:150.50M
Market Cap:2.33B
PE:-4.27
High:4.43
Open:4.02
Low:3.89
Close:3.95
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:0.78
T/O Rate:6.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.55
PE(LYR):-3.03

Loading ...

Movement Alert|Recursion Pharmaceuticals, Inc. Rises 8.1% in Regular Trading, Partnership Adjustment and Insider Selling Spur Divergence

Market Focus
·
Yesterday

Movement Alert|Recursion Pharmaceuticals, Inc. Falls 8.08% in Regular Trading, Insider Selling and Amended Tempus AI Agreement Weigh on Sentiment

Market Focus
·
Oct 08

Top Recursion Pharma Insider Makes a Major Move With His Shares

TIPRANKS
·
Oct 08

Cathie Wood’s ARK Investment buys 1.9M shares of Recursion Pharmaceuticals today

TIPRANKS
·
Oct 08

Recursion Director Robert Hershberg Sells 25,000 Common Shares for $125,000

Reuters
·
Oct 08

Movement Alert|Recursion Pharmaceuticals, Inc. Falls 8.21% in Regular Trading, Tempus Data License Amendment Spurs Market Divergence

Market Focus
·
Oct 08

Cathie Wood’s ARK Investment buys 1.5M shares of Recursion Pharmaceuticals today

TIPRANKS
·
Oct 06

NASD Most Active Issues

Dow Jones
·
Oct 06

Could Tempus RNA License Alter The Investment Case For Recursion Pharmaceuticals (RXRX)?

Simply Wall St.
·
Oct 03

One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model

AI Industry Frontlines
·
Oct 03

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

From Exoskeletons to AI: ChronoScale's Billion-Dollar Pivot

Tech News Roundup
·
Oct 02

Recursion Licenses TxFM RNA Foundation Model to Tempus AI for Oncology Use in USD 12 Million Deal

Reuters
·
Sep 22

Tempus Extends Data Licensing Partnership with Recursion Through November 2029

Reuters
·
Sep 22

Tempus AI, Recursion Extend Data License, Amend Fee Structure

MT Newswires Live
·
Sep 21

Recursion, Tempus Expand AI and RNA Collaboration Agreements

TIPRANKS
·
Sep 21

Tempus AI, Recursion extend data license agreement, enter new license agreement

TIPRANKS
·
Sep 21

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS
·
Sep 21

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model

THOMSON REUTERS
·
Sep 21

Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029

THOMSON REUTERS
·
Sep 21